Publicaciones en las que colabora con Philip Scheltens (17)

2024

  1. Association of Vascular Risk Factors and Cerebrovascular Pathology With Alzheimer Disease Pathologic Changes in Individuals Without Dementia

    Neurology, Vol. 103, Núm. 7

2023

  1. Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology

    Alzheimer's and Dementia, Vol. 19, Núm. 3, pp. 807-820

  2. Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning

    Genome Medicine, Vol. 15, Núm. 1

2022

  1. Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease (Molecular Neurodegeneration, (2022), 17, 1, (27), 10.1186/s13024-022-00521-3)

    Molecular Neurodegeneration

  2. Effects of age, amyloid, sex, and APOE ε4 on the CSF proteome in normal cognition

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 14, Núm. 1

  3. Functional eigenvector centrality dynamics are related to amyloid deposition in preclinical Alzheimer’s Disease

    Alzheimer's and Dementia

  4. Functional eigenvector centrality dynamics are related to amyloid deposition in preclinical Alzheimer’s Disease

    Alzheimer's and Dementia

  5. Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation

    Molecular Psychiatry, Vol. 27, Núm. 4, pp. 1990-1999

2020

  1. Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

    Translational Psychiatry, Vol. 10, Núm. 1

2018

  1. European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials

    Alzheimer's and Dementia, Vol. 14, Núm. 6, pp. 837-842

  2. MRI predictors of amyloid pathology: Results from the EMIF-AD Multimodal Biomarker Discovery study

    Alzheimer's Research and Therapy, Vol. 10, Núm. 1

  3. The EMIF-AD Multimodal Biomarker Discovery study: Design, methods and cohort characteristics

    Alzheimer's Research and Therapy, Vol. 10, Núm. 1

2016

  1. Gray matter network disruptions and amyloid beta in cognitively normal adults

    Neurobiology of Aging, Vol. 37, pp. 154-160

  2. Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study

    Alzheimer's and Dementia, Vol. 12, Núm. 2, pp. 154-163

2015

  1. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects

    Brain, Vol. 138, Núm. 9, pp. 2701-2715

2012

  1. Progression of Alzheimer disease in Europe: Data from the European ICTUS study

    Current Alzheimer Research, Vol. 9, Núm. 8, pp. 902-912

2008

  1. Multi-center comparison of medial temporal atrophy in patients with Alzheimer's disease - Data from the ICTUS study

    Dementia and Geriatric Cognitive Disorders, Vol. 26, Núm. 4, pp. 314-322